B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADCY9

MOLECULAR TARGET

adenylate cyclase 9

UniProt: O60503NCBI Gene: 11515 compounds

ADCY9 (adenylate cyclase 9) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADCY9

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Carmustine2.4010
2Edaravone2.4010
3Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as2.4010
4Iodoacetamide2.4010
5Cisplatin2.208
6Cilostazol1.956
7Disulfiram1.614
8Physostigmine1.614
9Ethylmaleimide1.614
10Physostigmine1.614
11tyrphostin 11.614
12myricetin-3-O-galactopyranoside [Supplementary Concept]1.102
13arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from1.102
14Aurintricarboxylic Acid1.102
15Diamide1.102

About ADCY9 as a Drug Target

ADCY9 (adenylate cyclase 9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented ADCY9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADCY9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.